Executive Director Research, Medical & Innovation Association of the British Pharmaceutical Industry (ABPI)
Virginia (Ginny) has worked in private sector and academia throughout her career, combining her interests in science policy research and innovation performance within and across organizations. She joined ABPI in 2015 to lead the organisation’s policy efforts for research, medical and innovation opportunities that will lead to better treatment for patients. Ginny is the senior ABPI lead for the association’s work on biologics, including biosimilars. Ginny previously worked for Amgen as Director, Global Regulatory and R&D Policy – Europe, Middle East and Africa. Previously, she spent nearly five years at Pfizer working on policy development and engagement in science, innovation and access and choice in healthcare. Ginny joined biopharma after a decade in academia where she held posts on innovation strategy at Imperial College Business School, the Science Policy Research Unit (SPRU), and the Centre for Research in Innovation Management (CENTRIM), as well as a post-doc role at London Business School. She is a Visiting Researcher in the Innovation & Entrepreneurship Department at Imperial College Business School.